Research Article

Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Table 2

Results from the study of precision.

Ruxolitinib concentration (μg/mL)Intraday precisionInterday precision
Mean peak area ± SD (n = 6)RSD (%)Mean peak area ± SD (n = 3)RSD (%)

170104.9 ± 0.80.8104.71 ± 0.80.8
200124.0 ± 1.00.9123.62 ± 0.80.7
230142.3 ± 1.00.7142.54 ± 0.90.6